As of April 1, 2026, Tonix Pharmaceuticals Holding Corp. (TNXP) trades at $13.68, marking a 0.51% decline in the latest trading session. This analysis explores key technical levels, recent market context for the biopharmaceutical stock, and potential near-term price scenarios based on current trading patterns. No recent earnings data is available for TNXP as of this writing, so price action is currently driven primarily by sector sentiment and technical flows rather than quarterly fundamental pe
TNXP Stock Analysis: Tonix Pharmaceuticals Holding Corp dips 0.51 pct to 13.68
TNXP - Stock Analysis
4063 Comments
1844 Likes
1
Algot
Legendary User
2 hours ago
The market remains above key moving averages, indicating stability.
👍 58
Reply
2
Qadir
Experienced Member
5 hours ago
Free US stock earnings trajectory analysis and revision trends to understand fundamental momentum and analyst sentiment changes over time. We track how analyst estimates have been changing over time to gauge improving or deteriorating expectations for companies. We provide estimate trends, trajectory analysis, and revision tracking for comprehensive coverage. Understand momentum with our comprehensive earnings trajectory and revision analysis tools for momentum investing.
👍 95
Reply
3
Janeta
Community Member
1 day ago
This feels like instructions I forgot.
👍 62
Reply
4
Eagle
Senior Contributor
1 day ago
I’d pay to watch you do this live. 💵
👍 28
Reply
5
Gabrien
Daily Reader
2 days ago
US stock options flow analysis and unusual options activity tracking to identify smart money positions in the market. Our options intelligence reveals hidden bets and sentiment indicators that often precede major price moves.
👍 92
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.